Fasting-mimicking diet and markers/risk factors for aging, diabetes, cancer, and cardiovascular disease

被引:370
作者
Wei, Min [1 ,2 ]
Brandhorst, Sebastian [1 ,2 ]
Shelehchi, Mahshid [1 ,2 ]
Mirzaei, Hamed [1 ,2 ]
Cheng, Chia Wei [1 ,2 ]
Budniak, Julia [1 ,2 ]
Groshen, Susan [3 ]
Mack, Wendy J. [3 ]
Guen, Esra [1 ,2 ]
Di Biase, Stefano [1 ,2 ]
Cohen, Pinchas [1 ,2 ]
Morgan, Todd E. [1 ,2 ]
Dorff, Tanya [4 ]
Hong, Kurt [5 ]
Michalsen, Andreas [6 ]
Laviano, Alessandro [7 ]
Longo, Valter D. [1 ,2 ,8 ]
机构
[1] Univ Southern Calif, Sch Gerontol, Longev Inst, Los Angeles, CA 90089 USA
[2] Univ Southern Calif, Dept Biol Sci, Los Angeles, CA 90089 USA
[3] Univ Southern Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA USA
[4] Univ Southern Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Los Angeles, CA 90033 USA
[5] Univ Southern Calif, Keck Sch Med, Dept Internal Med, Los Angeles, CA 90033 USA
[6] Charite Univ Med Ctr, Dept Internal & Complementary Med, D-10117 Berlin, Germany
[7] Sapienza Univ, Dept Clin Med, I-00185 Rome, Italy
[8] Italian Fdn Canc Res, Inst Mol Oncol, FIRC Inst Mol Oncol, I-20139 Milan, Italy
关键词
IGF-BINDING PROTEIN-3; GROWTH-HORMONE; WEIGHT-LOSS; ENERGY RESTRICTION; METABOLIC SYNDROME; BREAST-CANCER; RISK MARKERS; INSULIN; OVERWEIGHT; HEALTH;
D O I
10.1126/scitranslmed.aai8700
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Calorie restriction or changes in dietary composition can enhance healthy aging, but the inability of most subjects to adhere to chronic and extreme diets, as well as potentially adverse effects, limits their application. We randomized 100 generally healthy participants from the United States into two study arms and tested the effects of a fasting-mimicking diet (FMD)-low in calories, sugars, and protein but high in unsaturated fats-on markers/risk factors associated with aging and age-related diseases. We compared subjects who followed 3 months of an unrestricted diet to subjects who consumed the FMD for 5 consecutive days per month for 3 months. Three FMD cycles reduced body weight, trunk, and total body fat; lowered blood pressure; and decreased insulin-like growth factor 1 (IGF-1). No serious adverse effects were reported. After 3 months, control diet subjects were crossed over to the FMD program, resulting in a total of 71 subjects completing three FMD cycles. A post hoc analysis of subjects from both FMD arms showed that body mass index, blood pressure, fasting glucose, IGF-1, triglycerides, total and low-density lipoprotein cholesterol, and C-reactive protein were more beneficially affected in participants at risk for disease than in subjects who were not at risk. Thus, cycles of a 5-day FMD are safe, feasible, and effective in reducing markers/risk factors for aging and age-related diseases. Larger studies in patients with diagnosed diseases or selected on the basis of risk factors are warranted to confirm the effect of the FMD on disease prevention and treatment.
引用
收藏
页数:12
相关论文
共 42 条
[31]   Fasting: Molecular Mechanisms and Clinical Applications [J].
Longo, Valter D. ;
Mattson, Mark P. .
CELL METABOLISM, 2014, 19 (02) :181-192
[32]   Triglycerides and Cardiovascular Disease A Scientific Statement From the American Heart Association [J].
Miller, Michael ;
Stone, Neil J. ;
Ballantyne, Christie ;
Bittner, Vera ;
Criqui, Michael H. ;
Ginsberg, Henry N. ;
Goldberg, Anne Carol ;
Howard, William James ;
Jacobson, Marc S. ;
Kris-Etherton, Penny M. ;
Lennie, Terry A. ;
Levi, Moshe ;
Mazzone, Theodore ;
Pennathur, Subramanian .
CIRCULATION, 2011, 123 (20) :2292-2333
[33]  
Müller H, 2001, SCAND J RHEUMATOL, V30, P1, DOI 10.1080/030097401750065256
[34]   Recent Update to the US Cholesterol Treatment Guidelines A Comparison With International Guidelines [J].
Nayor, Matthew ;
Vasan, Ramachandran S. .
CIRCULATION, 2016, 133 (18) :1795-1806
[35]   Markers of inflammation and cardiovascular disease application to clinical and public health practice - A statement for healthcare professionals from the centers for disease control and prevention and the American Heart Association [J].
Pearson, TA ;
Mensah, GA ;
Alexander, RW ;
Anderson, JL ;
Cannon, RO ;
Criqui, M ;
Fadl, YY ;
Fortmann, SP ;
Hong, Y ;
Myers, GL ;
Rifai, N ;
Smith, SC ;
Taubert, K ;
Tracy, RP ;
Vinicor, F .
CIRCULATION, 2003, 107 (03) :499-511
[36]   Insulin, insulin-like growth factors, insulin resistance, and neoplasia [J].
Pollak, Michael N. .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 2007, 86 (03) :820S-822S
[37]   Fasting blood glucose and cancer risk in a cohort of more than 140,000 adults in Austria [J].
Rapp, K ;
Schroeder, J ;
Klenk, J ;
Ulmer, H ;
Concin, H ;
Diem, G ;
Oberaigner, W ;
Weiland, SK .
DIABETOLOGIA, 2006, 49 (05) :945-952
[38]   Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis [J].
Renehan, AG ;
Zwahlen, M ;
Minder, C ;
O'Dwyer, ST ;
Shalet, SM ;
Egger, M .
LANCET, 2004, 363 (9418) :1346-1353
[39]   Harmonizing the Metabolic Syndrome A Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity [J].
Alberti, K. G. M. M. ;
Eckel, Robert H. ;
Grundy, Scott M. ;
Zimmet, Paul Z. ;
Cleeman, James I. ;
Donato, Karen A. ;
Fruchart, Jean-Charles ;
James, W. Philip T. ;
Loria, Catherine M. ;
Smith, Sidney C., Jr. .
CIRCULATION, 2009, 120 (16) :1640-1645
[40]   Pleiotropic effects of growth hormone and insulin-like growth factor (IGF)-1 on biological aging: Inferences from moderate caloric-restricted animals [J].
Sonntag, WE ;
Lynch, CD ;
Cefalu, WT ;
Ingram, RL ;
Bennett, SA ;
Thornton, PL ;
Khan, AS .
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES, 1999, 54 (12) :B521-B538